{
  "caseId": "GBS_Trend_01",
  "itemId": "GBS_Trend_01_A",
  "itemType": "trend",
  "prompt": "The nurse is caring for a client with Guillain-Barre Syndrome (GBS) in the neurological intensive care unit. The nurse reviews the client's electronic health record. Which hypothesis about the client's condition is supported by the trended data?",
  "tabs": [
    {
      "id": "nurses_notes",
      "label": "Nurse's Notes",
      "content": "A 45-year-old client diagnosed with GBS 3 days ago after a recent gastrointestinal illness. The client was admitted for monitoring and initiation of intravenous immunoglobulin (IVIG) therapy. The client is alert and oriented x4 but reports increasing 'heaviness' in the arms and difficulty taking a deep breath."
    },
    {
      "id": "flowsheet",
      "label": "Flowsheet",
      "isTable": true,
      "data": [
        {
          "header": "Assessment",
          "isHeader": true
        },
        {
          "header": "Day 1 (Admission)",
          "isHeader": false
        },
        {
          "header": "Day 2",
          "isHeader": false
        },
        {
          "header": "Day 3 (Current)",
          "isHeader": false
        },
        {
          "data": [
            "Respiratory Rate (breaths/min)",
            "18",
            "22",
            "28"
          ]
        },
        {
          "data": [
            "SpO2 on Room Air (%)",
            "98",
            "96",
            "93"
          ]
        },
        {
          "data": [
            "Negative Inspiratory Force (NIF) (cm H2O)",
            "-55",
            "-40",
            "-25"
          ]
        },
        {
          "data": [
            "Heart Rate (beats/min)",
            "88",
            "105 (sinus tachycardia)",
            "115 (sinus tachycardia)"
          ]
        },
        {
          "data": [
            "Blood Pressure (mmHg)",
            "124/82",
            "148/90",
            "105/60"
          ]
        },
        {
          "data": [
            "Lower Extremity Motor Strength",
            "2/5 bilateral",
            "1/5 bilateral",
            "0/5 bilateral"
          ]
        },
        {
          "data": [
            "Upper Extremity Motor Strength",
            "4/5 bilateral",
            "3/5 bilateral",
            "2/5 bilateral"
          ]
        },
        {
          "data": [
            "Deep Tendon Reflexes (DTRs)",
            "1+ patellar",
            "0 patellar, 1+ biceps",
            "0 throughout"
          ]
        }
      ]
    }
  ],
  "options": [
    {
      "id": "opt_1",
      "label": "A",
      "text": "The client's condition is stabilizing as the IVIG therapy begins to take effect."
    },
    {
      "id": "opt_3",
      "label": "C",
      "text": "The client has developed a healthcare-associated pneumonia causing respiratory distress."
    },
    {
      "id": "opt_2",
      "label": "B",
      "text": "The client is experiencing progressive neuromuscular weakness and impending respiratory failure."
    },
    {
      "id": "opt_4",
      "label": "D",
      "text": "The client is experiencing a hypertensive crisis due to autonomic dysfunction."
    }
  ],
  "correctAnswer": [
    "opt_2"
  ],
  "rationale": {
    "correct": "The trended data indicates a rapid progression of GBS. The ascending motor weakness (lower extremities 2/5 to 0/5, upper extremities 4/5 to 2/5) and absent DTRs are characteristic. Critically, respiratory parameters are declining: increased respiratory rate (18 to 28), decreased SpO2 (98% to 93%), and worsening NIF (-55 to -25 cm H2O). This indicates weakening diaphragmatic and intercostal muscles, leading to impending respiratory failure. GBS causes demyelination of peripheral nerves, impairing nerve impulse transmission. This ascending paralysis can affect respiratory muscles, leading to hypoventilation and respiratory failure. Urgent intervention, such as intubation, may be required.",
    "incorrect": "The other options misinterpret the clinical data. The client's condition is worsening, not stabilizing. There are no signs of pneumonia (e.g., fever, productive cough, abnormal lung sounds). The respiratory decline is due to neuromuscular weakness. While autonomic dysfunction is present (labile BP and tachycardia), the client is hypotensive, not in a hypertensive crisis, and the primary issue is respiratory.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Incorrect. Multiple indicators are worsening: motor strength decline, increased respiratory rate, decreased SpO2, and critically worsened NIF. This contradicts stabilization.",
        "isCorrect": false
      },
      {
        "label": "B",
        "content": "Correct. Progressive motor weakness and loss of DTRs confirm neuromuscular weakness. NIF below -30 cm H2O, tachypnea, and decreased SpO2 indicate respiratory muscle fatigue and impending respiratory failure.",
        "isCorrect": true
      },
      {
        "label": "C",
        "content": "Incorrect. No data suggests pneumonia (fever, lung sounds, cough). Respiratory compromise is linked to neuromuscular weakness from GBS, shown by the NIF drop.",
        "isCorrect": false
      },
      {
        "label": "D",
        "content": "Incorrect. Labile blood pressure and tachycardia indicate autonomic dysfunction, but the client is hypotensive (105/60 mmHg), not hypertensive. The immediate threat is respiratory failure.",
        "isCorrect": false
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyzing",
    "cjmmStep": "Analyze Cues",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": 4,
    "topicTags": [
      "Guillain-Barre Syndrome",
      "Neurological Assessment",
      "Respiratory Failure",
      "Critical Care",
      "Trend Analysis"
    ],
    "clinicalPearls": [
      "Monitor respiratory status closely in GBS patients, especially NIF. Early intubation is crucial to prevent respiratory arrest.",
      "Autonomic dysfunction in GBS can cause labile blood pressure; monitor closely and manage accordingly.",
      "Ascending paralysis is a hallmark of GBS; document the progression of weakness carefully.",
      "IVIG therapy aims to reduce the severity and duration of GBS; monitor for infusion-related reactions."
    ],
    "sbar": {
      "situation": "45-year-old client with Guillain-Barre Syndrome (GBS), admitted 3 days ago following a GI illness, receiving IVIG therapy.",
      "background": "Client reports increasing arm heaviness and difficulty breathing deeply. Admitted for monitoring and IVIG initiation.",
      "assessment": "Progressive neuromuscular weakness evident: Lower extremity strength 2/5 to 0/5, upper extremity strength 4/5 to 2/5, DTRs absent. Respiratory rate increased from 18 to 28, SpO2 decreased from 98% to 93%, NIF worsened from -55 to -25 cm H2O. Heart rate increased from 88 to 115 (sinus tachycardia), blood pressure decreased from 124/82 to 105/60.",
      "recommendation": "Client is experiencing impending respiratory failure. Recommend immediate consultation with the intensivist, preparation for possible intubation and mechanical ventilation, and continuous monitoring of respiratory status. Notify respiratory therapy for urgent evaluation. Consider arterial blood gas (ABG) analysis."
    }
  },
  "sentinelStatus": "healed_v2026_v8"
}